Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation

被引：0
|
作者：
Hantel, Andrew
Wang, Yating
Abraham, Ivy
Patel, Anand Ashwin
Monick, Sarah Elizabeth
Rauscher, Garth H.
Rodriguez, Ana Maria Avila
Galvez, Carlos
Doukas, Peter
Altman, Jessica K.
Burkart, Madelyn
Erra, Amani
Zia, Maryam
Larson, Melissa L.
Dave, Ami Atulkumar
Tsai, Stephanie
Aleem, Ahmed
Raptis, Nepheli
Khan, Irum
Abel, Gregory A.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Chicago Med, Chicago, IL USA
[3] Univ Chicago Med Ctr, Chicago, IL USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ Illinois, Chicago, IL USA
[6] Northwestern Mem Hosp, Chicago, IL 60611 USA
[7] Robert H Lurie Comprehens Canc Ctr Northwestern U, Chicago, IL USA
[8] Atrium Hlth Wake Forest Baptist Comprehens Canc C, Winston Salem, NC USA
[9] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
[10] Rush Univ Med Ctr, Chicago, IL USA
[11] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[12] Loyola Univ Chicago, Maywood, IL USA
[13] Loyola Univ Chicago Stritch Sch Med, Forest Pk, IL USA
[14] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1589
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Racial and ethnic disparities in the incidence and mortality trends of acute myeloid leukemia in the United States
    Kang, Lixin
    Ma, Xiaomei
    Podoltsev, Nikolai A.
    Stempel, Jessica M.
    Wang, Rong
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (12)
  • [32] Decision criteria for the futility of intensive chemotherapy in older patients with acute myeloid leukemia (AML)
    Dombrel, Herve
    Malfuson, Jean-Valere
    Etienne, Anne
    Turlure, Pascal
    de Revel, Thierry
    Thomas, Xavier
    Contentin, Nathalie
    Terre, Christine
    Michallet, Mauricette
    Castaigne, Sylvie
    Bordessoule, Dominique
    Vey, Norbert
    Gardin, Claude
    BLOOD, 2007, 110 (11) : 841A - 842A
  • [33] How Do Differences in Treatment Impact Racial and Ethnic Disparities in Acute Myeloid Leukemia?
    Patel, Manali I.
    Ma, Yifei
    Mitchell, Beverly
    Rhoads, Kim F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (02) : 344 - 349
  • [34] NCI Common Toxicity Criteria and Mortality After Chemotherapy for Acute Myeloid Leukemia (AML)
    Veatch, Joshua R.
    Sandhu, Ravinder K.
    Shannon-Dorcy, Kathleen
    Pagel, John M.
    Becker, Pamela S.
    Petersdorf, Stephen
    Appelbaum, Frederick R.
    Estey, Elihu H.
    BLOOD, 2012, 120 (21)
  • [35] Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)
    H Iwata
    M Kami
    Y Kishi
    Y Oki
    Y Tanaka
    K Takeuchi
    I Yamazaki
    R Suzuki
    S Morinaga
    Y Mutou
    Leukemia, 2000, 14 : 2013 - 2014
  • [36] Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)
    Iwata, H
    Kami, M
    Kishi, Y
    Oki, Y
    Tanaka, Y
    Takeuchi, K
    Yamazaki, I
    Suzuki, R
    Morinaga, S
    Mutou, Y
    LEUKEMIA, 2000, 14 (11) : 2013 - 2014
  • [37] Characterization of Extramedullary Acute Myeloid Leukemia - Results of the AML96 Trial
    Stolzel, Friedrich
    Roellig, Christoph
    Kramer, Michael
    Mohr, Brigitte
    Oelschlaegel, Uta
    Radke, Joergen
    Thiede, Christian
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schaich, Markus
    BLOOD, 2010, 116 (21) : 889 - 890
  • [38] CLINICAL IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) IN ACUTE MYELOID LEUKEMIA (AML)
    Venditti, A.
    Buzzatti, E.
    Guarnera, L.
    Bonanni, F.
    Moretti, F.
    Pascale, M. R.
    Mallegni, F.
    Palmieri, R.
    Paterno, G.
    Del Principe, M. I.
    Maurillo, L.
    Voso, M. T.
    Buccisano, F.
    HAEMATOLOGICA, 2021, 106 (10) : 202 - 205
  • [39] Anticardiolipin antibodies in acute myeloid leukemia (AML): Prevalence and clinical significance.
    Lossos, IS
    Matzner, Y
    BLOOD, 1997, 90 (10) : 3713 - 3713
  • [40] Intrinsic susceptibility to apoptosis predicts clinical response of acute myeloid leukemia (AML).
    Smith, BD
    Bambach, BJ
    Ni, W
    Vala, MS
    Barber, JP
    Brodsky, RA
    Burke, PJ
    Gore, SD
    Jones, RJ
    BLOOD, 1999, 94 (10) : 695A - 695A
12345